Co-amoxiclav 250mg+62,5mg DT PAC-5x10

General description:
Co-amoxiclav 250mg + 62.5mg dispersible tablets. 5 blister cards containing 10 dispersible tablets.

Technical specifications:
Each dispersible tablet contains Amoxicillin Trihydrate equivalent to 250mg Amoxicillin and Potassium Clavulanate equivalent to 62,5mg Clavulanic acid.

Therapeutic class:
Amoxicillin is a beta-Lactam
Clavulanic acid is a beta-Lactamase inhibitor.

Indications
Treatment of bacterial infections susceptible to Amoxicillin and Clavulanate Potassium either alone or in combination with other antibiotics.

Dosage, Instructions for use
Refer to the guidelines below:
WHO Model Formulary 2008
http://www.who.int/selection_medicines/list/WMF2008.pdf

WHO Model Formulary for Children 2010
http://www.who.int/selection_medicines/list/WMFc_2010.pdf

Shelf life:
3 years (36 months).

Storage and transportation
This product must be transported between +15° C to +25° C.

Component of a KIT
No.

Alternative products:
S1533302 Co-Amoxiclav 125mg+ 31.25mg BOT/100ml.